Back
Edgewise Therapeutics Stock Price Chart
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
34
EWTX
Edgewise Therapeutics
Last Price:
$26.26
Seasonality Move:
-10.93%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing selling pressure, which indicates risk of future bearish movement.
Edgewise Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.13 | Buy |
| 20-day SMA: | 27.68 | Sell |
| 50-day SMA: | 30.43 | Sell |
| 200-day SMA: | 23.23 | Buy |
| 8-day EMA: | 26.65 | Sell |
| 20-day EMA: | 27.55 | Sell |
| 50-day EMA: | 28.82 | Sell |
| 200-day EMA: | 24.12 | Buy |
Edgewise Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.12 | Sell |
| Relative Strength Index (14 RSI): | 42.66 | Sell |
| Chaikin Money Flow: | -546635 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.03 - 30.13) | Sell |
| Bollinger Bands (100): | (22.77 - 33.95) | Sell |
Edgewise Therapeutics Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
-
Edgewise Therapeutics share price is 26.26 while EWTX 8-day simple moving average is 26.13, which is a Buy signal.
-
The stock price of EWTX is 26.26 while Edgewise Therapeutics 20-day SMA is 27.68, which makes it a Sell.
-
Edgewise Therapeutics 50-day simple moving average is 30.43 while EWTX share price is 26.26, making it a Sell technically.
-
EWTX stock price is 26.26 and Edgewise Therapeutics 200-day simple moving average is 23.23, creating a Buy signal.
EWTX Technical Analysis vs Fundamental Analysis
Sell
34
Edgewise Therapeutics (EWTX)
is a Sell
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a SellThe current Edgewise Therapeutics [EWTX] share price is $26.26. The Score for EWTX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
2.5B
Price in USD:
26.26
Share Volume:
573.9K
Edgewise Therapeutics 52-Week Range
52-Week High:
38.12
52-Week Low:
11.91
Sell
34
Edgewise Therapeutics (EWTX)
is a Sell
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?The Edgewise Therapeutics stock price is 26.26 USD today.
-
Will EWTX stock go up or go down?Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Edgewise Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is overvalued.
Is Edgewise Therapeutics Stock a Buy?
-
Edgewise Therapeutics share price is 26.26 while EWTX 8-day exponential moving average is 26.65, which is a Sell signal.
-
The stock price of EWTX is 26.26 while Edgewise Therapeutics 20-day EMA is 27.55, which makes it a Sell.
-
Edgewise Therapeutics 50-day exponential moving average is 28.82 while EWTX share price is 26.26, making it a Sell technically.
-
EWTX stock price is 26.26 and Edgewise Therapeutics 200-day simple moving average is 24.12, creating a Buy signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and a decrease next year of $0.35 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
-
EWTX Moving Average Covergence Divergence (MACD) indicator is -1.12, suggesting Edgewise Therapeutics is a Sell
-
Edgewise Therapeutics Relative Strength Index (RSI) is 42.66, which suggest Edgewise Therapeutics is oversold
-
The Bollinger Bands (25) for Edgewise Therapeutics is (26.03 - 30.13), which suggest Edgewise Therapeutics is a Sell
-
The Bollinger Bands (100) for Edgewise Therapeutics is (22.77 - 33.95), which suggest Edgewise Therapeutics is a Sell
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.